Royalty Agreement Dated 2008Royalty Agreement • November 20th, 2008 • Acrongenomics Inc • Surgical & medical instruments & apparatus
Molecular Vision Limited (registered in England under number 4292847) whose registered office is at BioIncubator Unit, Bessemer Building, Prince Consort Road, London SW7 2BP ("Molecular Vision");
SHARE TRANSFER AGREEMENTShare Transfer Agreement • February 2nd, 2004 • Cellway Ventures Inc • Non-operating establishments
THIS AGREEMENT WITNESSES THAT in consideration of the payment of $35,000 US, and other good and valuable consideration, by the Transferee to the Transferor, payable at closing, the sufficiency of which is acknowledged, and in reliance of the representations and warranties of the Transferee, the Transferor hereby agrees to sell, assign and transfer to the Transferee an aggregate of up to 5,000,000 shares of common stock of CELLWAY VENTURES, INC. (the “Company”) (the “Shares”) free and clear of all liens, charges and encumbrances. The Transferee acknowledges and agrees that the Shares are restricted shares, as contemplated under the United States Securities Act of 1933 (the “1933 Act”) which have been issued to the Transferor pursuant to Section 4(2) of the 1933 Act without registration and that all share certificates representing the Shares will be endorsed with the following legend:
Option Agreement (subscription for shares) Dated 2008Option Agreement • November 20th, 2008 • Acrongenomics Inc • Surgical & medical instruments & apparatus
AGREEMENT FOR THE SALE OF STOCKStock Sale Agreement • February 16th, 2006 • Acrongenomics Inc • In vitro & in vivo diagnostic substances • Nevada
THIS AGREEMENT (“Agreement”) is effective as of today, February 13, 2006, by and between Acrongenomics, Inc., a Nevada corporation (“Acron”) and Dr. Eleftherios Georgakopoulos, son of Nickolas, an individual residing at 47-49 Bouboulinas Street, Ag. Paraskevi in Athens, Greece, holder of Greek ID card nr. X 050249 (“Dr. Georgakopoulos”).
